nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefpodoxime—Syncope—Triamcinolone—ankylosing spondylitis	0.00263	0.00263	CcSEcCtD
Cefpodoxime—Vertigo—Methylprednisolone—ankylosing spondylitis	0.00263	0.00263	CcSEcCtD
Cefpodoxime—Syncope—Methylprednisolone—ankylosing spondylitis	0.00262	0.00262	CcSEcCtD
Cefpodoxime—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.0026	0.0026	CcSEcCtD
Cefpodoxime—Dysuria—Methotrexate—ankylosing spondylitis	0.0026	0.0026	CcSEcCtD
Cefpodoxime—Neutropenia—Methotrexate—ankylosing spondylitis	0.0026	0.0026	CcSEcCtD
Cefpodoxime—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.00258	0.00258	CcSEcCtD
Cefpodoxime—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.00257	0.00257	CcSEcCtD
Cefpodoxime—Shock—Prednisolone—ankylosing spondylitis	0.00256	0.00256	CcSEcCtD
Cefpodoxime—Cough—Triamcinolone—ankylosing spondylitis	0.00256	0.00256	CcSEcCtD
Cefpodoxime—Convulsion—Triamcinolone—ankylosing spondylitis	0.00254	0.00254	CcSEcCtD
Cefpodoxime—Photosensitivity reaction—Methotrexate—ankylosing spondylitis	0.00254	0.00254	CcSEcCtD
Cefpodoxime—Convulsion—Methylprednisolone—ankylosing spondylitis	0.00253	0.00253	CcSEcCtD
Cefpodoxime—Hypertension—Triamcinolone—ankylosing spondylitis	0.00253	0.00253	CcSEcCtD
Cefpodoxime—Hypertension—Methylprednisolone—ankylosing spondylitis	0.00253	0.00253	CcSEcCtD
Cefpodoxime—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.00252	0.00252	CcSEcCtD
Cefpodoxime—Myalgia—Triamcinolone—ankylosing spondylitis	0.0025	0.0025	CcSEcCtD
Cefpodoxime—Pneumonia—Methotrexate—ankylosing spondylitis	0.00249	0.00249	CcSEcCtD
Cefpodoxime—Myalgia—Methylprednisolone—ankylosing spondylitis	0.00249	0.00249	CcSEcCtD
Cefpodoxime—Anxiety—Methylprednisolone—ankylosing spondylitis	0.00248	0.00248	CcSEcCtD
Cefpodoxime—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.00247	0.00247	CcSEcCtD
Cefpodoxime—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.00247	0.00247	CcSEcCtD
Cefpodoxime—Discomfort—Triamcinolone—ankylosing spondylitis	0.00247	0.00247	CcSEcCtD
Cefpodoxime—Discomfort—Methylprednisolone—ankylosing spondylitis	0.00246	0.00246	CcSEcCtD
Cefpodoxime—Stevens-Johnson syndrome—Methotrexate—ankylosing spondylitis	0.00246	0.00246	CcSEcCtD
Cefpodoxime—Dry mouth—Triamcinolone—ankylosing spondylitis	0.00244	0.00244	CcSEcCtD
Cefpodoxime—Renal failure—Methotrexate—ankylosing spondylitis	0.00244	0.00244	CcSEcCtD
Cefpodoxime—Stomatitis—Methotrexate—ankylosing spondylitis	0.00242	0.00242	CcSEcCtD
Cefpodoxime—Confusional state—Methylprednisolone—ankylosing spondylitis	0.00241	0.00241	CcSEcCtD
Cefpodoxime—Malaise—Betamethasone—ankylosing spondylitis	0.0024	0.0024	CcSEcCtD
Cefpodoxime—Malaise—Dexamethasone—ankylosing spondylitis	0.0024	0.0024	CcSEcCtD
Cefpodoxime—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.00239	0.00239	CcSEcCtD
Cefpodoxime—Vertigo—Dexamethasone—ankylosing spondylitis	0.00239	0.00239	CcSEcCtD
Cefpodoxime—Vertigo—Betamethasone—ankylosing spondylitis	0.00239	0.00239	CcSEcCtD
Cefpodoxime—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.00239	0.00239	CcSEcCtD
Cefpodoxime—Syncope—Dexamethasone—ankylosing spondylitis	0.00239	0.00239	CcSEcCtD
Cefpodoxime—Syncope—Betamethasone—ankylosing spondylitis	0.00239	0.00239	CcSEcCtD
Cefpodoxime—Haematuria—Methotrexate—ankylosing spondylitis	0.00236	0.00236	CcSEcCtD
Cefpodoxime—Shock—Triamcinolone—ankylosing spondylitis	0.00235	0.00235	CcSEcCtD
Cefpodoxime—Insomnia—Prednisolone—ankylosing spondylitis	0.00235	0.00235	CcSEcCtD
Cefpodoxime—Alopecia—Prednisone—ankylosing spondylitis	0.00235	0.00235	CcSEcCtD
Cefpodoxime—Shock—Methylprednisolone—ankylosing spondylitis	0.00235	0.00235	CcSEcCtD
Cefpodoxime—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.00234	0.00234	CcSEcCtD
Cefpodoxime—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.00234	0.00234	CcSEcCtD
Cefpodoxime—Epistaxis—Methotrexate—ankylosing spondylitis	0.00234	0.00234	CcSEcCtD
Cefpodoxime—Paraesthesia—Prednisolone—ankylosing spondylitis	0.00234	0.00234	CcSEcCtD
Cefpodoxime—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.00231	0.00231	CcSEcCtD
Cefpodoxime—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.00231	0.00231	CcSEcCtD
Cefpodoxime—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.00231	0.00231	CcSEcCtD
Cefpodoxime—Convulsion—Dexamethasone—ankylosing spondylitis	0.0023	0.0023	CcSEcCtD
Cefpodoxime—Convulsion—Betamethasone—ankylosing spondylitis	0.0023	0.0023	CcSEcCtD
Cefpodoxime—Hypertension—Dexamethasone—ankylosing spondylitis	0.0023	0.0023	CcSEcCtD
Cefpodoxime—Hypertension—Betamethasone—ankylosing spondylitis	0.0023	0.0023	CcSEcCtD
Cefpodoxime—Myalgia—Dexamethasone—ankylosing spondylitis	0.00226	0.00226	CcSEcCtD
Cefpodoxime—Myalgia—Betamethasone—ankylosing spondylitis	0.00226	0.00226	CcSEcCtD
Cefpodoxime—Anxiety—Dexamethasone—ankylosing spondylitis	0.00226	0.00226	CcSEcCtD
Cefpodoxime—Anxiety—Betamethasone—ankylosing spondylitis	0.00226	0.00226	CcSEcCtD
Cefpodoxime—Discomfort—Betamethasone—ankylosing spondylitis	0.00224	0.00224	CcSEcCtD
Cefpodoxime—Discomfort—Dexamethasone—ankylosing spondylitis	0.00224	0.00224	CcSEcCtD
Cefpodoxime—Haemoglobin—Methotrexate—ankylosing spondylitis	0.00224	0.00224	CcSEcCtD
Cefpodoxime—Hypotension—Methylprednisolone—ankylosing spondylitis	0.00223	0.00223	CcSEcCtD
Cefpodoxime—Pain—Prednisolone—ankylosing spondylitis	0.00223	0.00223	CcSEcCtD
Cefpodoxime—Haemorrhage—Methotrexate—ankylosing spondylitis	0.00222	0.00222	CcSEcCtD
Cefpodoxime—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.00218	0.00218	CcSEcCtD
Cefpodoxime—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.00218	0.00218	CcSEcCtD
Cefpodoxime—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.00217	0.00217	CcSEcCtD
Cefpodoxime—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.00217	0.00217	CcSEcCtD
Cefpodoxime—Insomnia—Triamcinolone—ankylosing spondylitis	0.00216	0.00216	CcSEcCtD
Cefpodoxime—Insomnia—Methylprednisolone—ankylosing spondylitis	0.00216	0.00216	CcSEcCtD
Cefpodoxime—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.00215	0.00215	CcSEcCtD
Cefpodoxime—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.00215	0.00215	CcSEcCtD
Cefpodoxime—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.00214	0.00214	CcSEcCtD
Cefpodoxime—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.00214	0.00214	CcSEcCtD
Cefpodoxime—Anaemia—Prednisone—ankylosing spondylitis	0.00214	0.00214	CcSEcCtD
Cefpodoxime—Shock—Betamethasone—ankylosing spondylitis	0.00214	0.00214	CcSEcCtD
Cefpodoxime—Shock—Dexamethasone—ankylosing spondylitis	0.00214	0.00214	CcSEcCtD
Cefpodoxime—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.00213	0.00213	CcSEcCtD
Cefpodoxime—Agitation—Prednisone—ankylosing spondylitis	0.00213	0.00213	CcSEcCtD
Cefpodoxime—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.00213	0.00213	CcSEcCtD
Cefpodoxime—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.00213	0.00213	CcSEcCtD
Cefpodoxime—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.00211	0.00211	CcSEcCtD
Cefpodoxime—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.0021	0.0021	CcSEcCtD
Cefpodoxime—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.0021	0.0021	CcSEcCtD
Cefpodoxime—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.0021	0.0021	CcSEcCtD
Cefpodoxime—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.0021	0.0021	CcSEcCtD
Cefpodoxime—Malaise—Prednisone—ankylosing spondylitis	0.00209	0.00209	CcSEcCtD
Cefpodoxime—Vertigo—Prednisone—ankylosing spondylitis	0.00208	0.00208	CcSEcCtD
Cefpodoxime—Syncope—Prednisone—ankylosing spondylitis	0.00208	0.00208	CcSEcCtD
Cefpodoxime—Tinnitus—Methotrexate—ankylosing spondylitis	0.00207	0.00207	CcSEcCtD
Cefpodoxime—Anorexia—Dexamethasone—ankylosing spondylitis	0.00207	0.00207	CcSEcCtD
Cefpodoxime—Anorexia—Betamethasone—ankylosing spondylitis	0.00207	0.00207	CcSEcCtD
Cefpodoxime—Urticaria—Prednisolone—ankylosing spondylitis	0.00207	0.00207	CcSEcCtD
Cefpodoxime—Fatigue—Triamcinolone—ankylosing spondylitis	0.00206	0.00206	CcSEcCtD
Cefpodoxime—Fatigue—Methylprednisolone—ankylosing spondylitis	0.00206	0.00206	CcSEcCtD
Cefpodoxime—Pain—Triamcinolone—ankylosing spondylitis	0.00205	0.00205	CcSEcCtD
Cefpodoxime—Loss of consciousness—Prednisone—ankylosing spondylitis	0.00204	0.00204	CcSEcCtD
Cefpodoxime—Hypotension—Betamethasone—ankylosing spondylitis	0.00203	0.00203	CcSEcCtD
Cefpodoxime—Hypotension—Dexamethasone—ankylosing spondylitis	0.00203	0.00203	CcSEcCtD
Cefpodoxime—Convulsion—Prednisone—ankylosing spondylitis	0.00201	0.00201	CcSEcCtD
Cefpodoxime—Hypertension—Prednisone—ankylosing spondylitis	0.002	0.002	CcSEcCtD
Cefpodoxime—Chills—Methotrexate—ankylosing spondylitis	0.002	0.002	CcSEcCtD
Cefpodoxime—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.00198	0.00198	CcSEcCtD
Cefpodoxime—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.00198	0.00198	CcSEcCtD
Cefpodoxime—Myalgia—Prednisone—ankylosing spondylitis	0.00197	0.00197	CcSEcCtD
Cefpodoxime—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.00197	0.00197	CcSEcCtD
Cefpodoxime—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.00197	0.00197	CcSEcCtD
Cefpodoxime—Anxiety—Prednisone—ankylosing spondylitis	0.00197	0.00197	CcSEcCtD
Cefpodoxime—Alopecia—Methotrexate—ankylosing spondylitis	0.00197	0.00197	CcSEcCtD
Cefpodoxime—Insomnia—Betamethasone—ankylosing spondylitis	0.00196	0.00196	CcSEcCtD
Cefpodoxime—Insomnia—Dexamethasone—ankylosing spondylitis	0.00196	0.00196	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.00195	0.00195	CcSEcCtD
Cefpodoxime—Paraesthesia—Betamethasone—ankylosing spondylitis	0.00195	0.00195	CcSEcCtD
Cefpodoxime—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.00195	0.00195	CcSEcCtD
Cefpodoxime—Discomfort—Prednisone—ankylosing spondylitis	0.00195	0.00195	CcSEcCtD
Cefpodoxime—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.00192	0.00192	CcSEcCtD
Cefpodoxime—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.00191	0.00191	CcSEcCtD
Cefpodoxime—Dyspepsia—Betamethasone—ankylosing spondylitis	0.00191	0.00191	CcSEcCtD
Cefpodoxime—Urticaria—Triamcinolone—ankylosing spondylitis	0.0019	0.0019	CcSEcCtD
Cefpodoxime—Urticaria—Methylprednisolone—ankylosing spondylitis	0.0019	0.0019	CcSEcCtD
Cefpodoxime—Dysgeusia—Methotrexate—ankylosing spondylitis	0.0019	0.0019	CcSEcCtD
Cefpodoxime—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.00189	0.00189	CcSEcCtD
Cefpodoxime—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.00189	0.00189	CcSEcCtD
Cefpodoxime—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.00189	0.00189	CcSEcCtD
Cefpodoxime—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.00189	0.00189	CcSEcCtD
Cefpodoxime—Decreased appetite—Betamethasone—ankylosing spondylitis	0.00189	0.00189	CcSEcCtD
Cefpodoxime—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.00187	0.00187	CcSEcCtD
Cefpodoxime—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.00187	0.00187	CcSEcCtD
Cefpodoxime—Back pain—Methotrexate—ankylosing spondylitis	0.00187	0.00187	CcSEcCtD
Cefpodoxime—Fatigue—Dexamethasone—ankylosing spondylitis	0.00187	0.00187	CcSEcCtD
Cefpodoxime—Fatigue—Betamethasone—ankylosing spondylitis	0.00187	0.00187	CcSEcCtD
Cefpodoxime—Shock—Prednisone—ankylosing spondylitis	0.00186	0.00186	CcSEcCtD
Cefpodoxime—Pain—Dexamethasone—ankylosing spondylitis	0.00186	0.00186	CcSEcCtD
Cefpodoxime—Pain—Betamethasone—ankylosing spondylitis	0.00186	0.00186	CcSEcCtD
Cefpodoxime—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.00183	0.00183	CcSEcCtD
Cefpodoxime—Anorexia—Prednisone—ankylosing spondylitis	0.0018	0.0018	CcSEcCtD
Cefpodoxime—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.0018	0.0018	CcSEcCtD
Cefpodoxime—Anaemia—Methotrexate—ankylosing spondylitis	0.00179	0.00179	CcSEcCtD
Cefpodoxime—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.00179	0.00179	CcSEcCtD
Cefpodoxime—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.00179	0.00179	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.00178	0.00178	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.00178	0.00178	CcSEcCtD
Cefpodoxime—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.00176	0.00176	CcSEcCtD
Cefpodoxime—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.00176	0.00176	CcSEcCtD
Cefpodoxime—Malaise—Methotrexate—ankylosing spondylitis	0.00175	0.00175	CcSEcCtD
Cefpodoxime—Vertigo—Methotrexate—ankylosing spondylitis	0.00174	0.00174	CcSEcCtD
Cefpodoxime—Leukopenia—Methotrexate—ankylosing spondylitis	0.00173	0.00173	CcSEcCtD
Cefpodoxime—Urticaria—Betamethasone—ankylosing spondylitis	0.00172	0.00172	CcSEcCtD
Cefpodoxime—Urticaria—Dexamethasone—ankylosing spondylitis	0.00172	0.00172	CcSEcCtD
Cefpodoxime—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.00172	0.00172	CcSEcCtD
Cefpodoxime—Dizziness—Prednisolone—ankylosing spondylitis	0.00172	0.00172	CcSEcCtD
Cefpodoxime—Asthenia—Triamcinolone—ankylosing spondylitis	0.00172	0.00172	CcSEcCtD
Cefpodoxime—Body temperature increased—Betamethasone—ankylosing spondylitis	0.00172	0.00172	CcSEcCtD
Cefpodoxime—Abdominal pain—Betamethasone—ankylosing spondylitis	0.00172	0.00172	CcSEcCtD
Cefpodoxime—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.00172	0.00172	CcSEcCtD
Cefpodoxime—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.00172	0.00172	CcSEcCtD
Cefpodoxime—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00171	0.00171	CcSEcCtD
Cefpodoxime—Insomnia—Prednisone—ankylosing spondylitis	0.00171	0.00171	CcSEcCtD
Cefpodoxime—Paraesthesia—Prednisone—ankylosing spondylitis	0.0017	0.0017	CcSEcCtD
Cefpodoxime—Pruritus—Triamcinolone—ankylosing spondylitis	0.00169	0.00169	CcSEcCtD
Cefpodoxime—Cough—Methotrexate—ankylosing spondylitis	0.00169	0.00169	CcSEcCtD
Cefpodoxime—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00169	0.00169	CcSEcCtD
Cefpodoxime—Convulsion—Methotrexate—ankylosing spondylitis	0.00168	0.00168	CcSEcCtD
Cefpodoxime—Dyspepsia—Prednisone—ankylosing spondylitis	0.00166	0.00166	CcSEcCtD
Cefpodoxime—Chest pain—Methotrexate—ankylosing spondylitis	0.00165	0.00165	CcSEcCtD
Cefpodoxime—Myalgia—Methotrexate—ankylosing spondylitis	0.00165	0.00165	CcSEcCtD
Cefpodoxime—Decreased appetite—Prednisone—ankylosing spondylitis	0.00164	0.00164	CcSEcCtD
Cefpodoxime—Rash—Prednisolone—ankylosing spondylitis	0.00164	0.00164	CcSEcCtD
Cefpodoxime—Dermatitis—Prednisolone—ankylosing spondylitis	0.00164	0.00164	CcSEcCtD
Cefpodoxime—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00163	0.00163	CcSEcCtD
Cefpodoxime—Fatigue—Prednisone—ankylosing spondylitis	0.00163	0.00163	CcSEcCtD
Cefpodoxime—Headache—Prednisolone—ankylosing spondylitis	0.00163	0.00163	CcSEcCtD
Cefpodoxime—Discomfort—Methotrexate—ankylosing spondylitis	0.00163	0.00163	CcSEcCtD
Cefpodoxime—Constipation—Prednisone—ankylosing spondylitis	0.00162	0.00162	CcSEcCtD
Cefpodoxime—Confusional state—Methotrexate—ankylosing spondylitis	0.00159	0.00159	CcSEcCtD
Cefpodoxime—Dizziness—Triamcinolone—ankylosing spondylitis	0.00158	0.00158	CcSEcCtD
Cefpodoxime—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.00158	0.00158	CcSEcCtD
Cefpodoxime—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00158	0.00158	CcSEcCtD
Cefpodoxime—Feeling abnormal—Prednisone—ankylosing spondylitis	0.00156	0.00156	CcSEcCtD
Cefpodoxime—Asthenia—Betamethasone—ankylosing spondylitis	0.00156	0.00156	CcSEcCtD
Cefpodoxime—Asthenia—Dexamethasone—ankylosing spondylitis	0.00156	0.00156	CcSEcCtD
Cefpodoxime—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.00155	0.00155	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.00155	0.00155	CcSEcCtD
Cefpodoxime—Nausea—Prednisolone—ankylosing spondylitis	0.00155	0.00155	CcSEcCtD
Cefpodoxime—Pruritus—Betamethasone—ankylosing spondylitis	0.00154	0.00154	CcSEcCtD
Cefpodoxime—Pruritus—Dexamethasone—ankylosing spondylitis	0.00154	0.00154	CcSEcCtD
Cefpodoxime—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.00153	0.00153	CcSEcCtD
Cefpodoxime—Vomiting—Triamcinolone—ankylosing spondylitis	0.00152	0.00152	CcSEcCtD
Cefpodoxime—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00152	0.00152	CcSEcCtD
Cefpodoxime—Rash—Triamcinolone—ankylosing spondylitis	0.00151	0.00151	CcSEcCtD
Cefpodoxime—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00151	0.00151	CcSEcCtD
Cefpodoxime—Anorexia—Methotrexate—ankylosing spondylitis	0.00151	0.00151	CcSEcCtD
Cefpodoxime—Rash—Methylprednisolone—ankylosing spondylitis	0.00151	0.00151	CcSEcCtD
Cefpodoxime—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.0015	0.0015	CcSEcCtD
Cefpodoxime—Urticaria—Prednisone—ankylosing spondylitis	0.0015	0.0015	CcSEcCtD
Cefpodoxime—Headache—Triamcinolone—ankylosing spondylitis	0.0015	0.0015	CcSEcCtD
Cefpodoxime—Headache—Methylprednisolone—ankylosing spondylitis	0.0015	0.0015	CcSEcCtD
Cefpodoxime—Abdominal pain—Prednisone—ankylosing spondylitis	0.00149	0.00149	CcSEcCtD
Cefpodoxime—Body temperature increased—Prednisone—ankylosing spondylitis	0.00149	0.00149	CcSEcCtD
Cefpodoxime—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.00149	0.00149	CcSEcCtD
Cefpodoxime—Diarrhoea—Betamethasone—ankylosing spondylitis	0.00149	0.00149	CcSEcCtD
Cefpodoxime—Hypotension—Methotrexate—ankylosing spondylitis	0.00148	0.00148	CcSEcCtD
Cefpodoxime—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.00144	0.00144	CcSEcCtD
Cefpodoxime—Dizziness—Betamethasone—ankylosing spondylitis	0.00144	0.00144	CcSEcCtD
Cefpodoxime—Dizziness—Dexamethasone—ankylosing spondylitis	0.00144	0.00144	CcSEcCtD
Cefpodoxime—Insomnia—Methotrexate—ankylosing spondylitis	0.00143	0.00143	CcSEcCtD
Cefpodoxime—Nausea—Triamcinolone—ankylosing spondylitis	0.00142	0.00142	CcSEcCtD
Cefpodoxime—Paraesthesia—Methotrexate—ankylosing spondylitis	0.00142	0.00142	CcSEcCtD
Cefpodoxime—Nausea—Methylprednisolone—ankylosing spondylitis	0.00142	0.00142	CcSEcCtD
Cefpodoxime—Dyspnoea—Methotrexate—ankylosing spondylitis	0.00141	0.00141	CcSEcCtD
Cefpodoxime—Somnolence—Methotrexate—ankylosing spondylitis	0.0014	0.0014	CcSEcCtD
Cefpodoxime—Hypersensitivity—Prednisone—ankylosing spondylitis	0.00139	0.00139	CcSEcCtD
Cefpodoxime—Dyspepsia—Methotrexate—ankylosing spondylitis	0.00139	0.00139	CcSEcCtD
Cefpodoxime—Vomiting—Dexamethasone—ankylosing spondylitis	0.00138	0.00138	CcSEcCtD
Cefpodoxime—Vomiting—Betamethasone—ankylosing spondylitis	0.00138	0.00138	CcSEcCtD
Cefpodoxime—Decreased appetite—Methotrexate—ankylosing spondylitis	0.00137	0.00137	CcSEcCtD
Cefpodoxime—Rash—Betamethasone—ankylosing spondylitis	0.00137	0.00137	CcSEcCtD
Cefpodoxime—Rash—Dexamethasone—ankylosing spondylitis	0.00137	0.00137	CcSEcCtD
Cefpodoxime—Dermatitis—Dexamethasone—ankylosing spondylitis	0.00137	0.00137	CcSEcCtD
Cefpodoxime—Dermatitis—Betamethasone—ankylosing spondylitis	0.00137	0.00137	CcSEcCtD
Cefpodoxime—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.00136	0.00136	CcSEcCtD
Cefpodoxime—Fatigue—Methotrexate—ankylosing spondylitis	0.00136	0.00136	CcSEcCtD
Cefpodoxime—Headache—Betamethasone—ankylosing spondylitis	0.00136	0.00136	CcSEcCtD
Cefpodoxime—Headache—Dexamethasone—ankylosing spondylitis	0.00136	0.00136	CcSEcCtD
Cefpodoxime—Asthenia—Prednisone—ankylosing spondylitis	0.00136	0.00136	CcSEcCtD
Cefpodoxime—Pain—Methotrexate—ankylosing spondylitis	0.00135	0.00135	CcSEcCtD
Cefpodoxime—Pruritus—Prednisone—ankylosing spondylitis	0.00134	0.00134	CcSEcCtD
Cefpodoxime—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.0013	0.0013	CcSEcCtD
Cefpodoxime—Diarrhoea—Prednisone—ankylosing spondylitis	0.00129	0.00129	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.00129	0.00129	CcSEcCtD
Cefpodoxime—Nausea—Betamethasone—ankylosing spondylitis	0.00129	0.00129	CcSEcCtD
Cefpodoxime—Nausea—Dexamethasone—ankylosing spondylitis	0.00129	0.00129	CcSEcCtD
Cefpodoxime—Urticaria—Methotrexate—ankylosing spondylitis	0.00126	0.00126	CcSEcCtD
Cefpodoxime—Dizziness—Prednisone—ankylosing spondylitis	0.00125	0.00125	CcSEcCtD
Cefpodoxime—Abdominal pain—Methotrexate—ankylosing spondylitis	0.00125	0.00125	CcSEcCtD
Cefpodoxime—Body temperature increased—Methotrexate—ankylosing spondylitis	0.00125	0.00125	CcSEcCtD
Cefpodoxime—Vomiting—Prednisone—ankylosing spondylitis	0.0012	0.0012	CcSEcCtD
Cefpodoxime—Rash—Prednisone—ankylosing spondylitis	0.00119	0.00119	CcSEcCtD
Cefpodoxime—Dermatitis—Prednisone—ankylosing spondylitis	0.00119	0.00119	CcSEcCtD
Cefpodoxime—Headache—Prednisone—ankylosing spondylitis	0.00118	0.00118	CcSEcCtD
Cefpodoxime—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.00116	0.00116	CcSEcCtD
Cefpodoxime—Asthenia—Methotrexate—ankylosing spondylitis	0.00113	0.00113	CcSEcCtD
Cefpodoxime—Nausea—Prednisone—ankylosing spondylitis	0.00112	0.00112	CcSEcCtD
Cefpodoxime—Pruritus—Methotrexate—ankylosing spondylitis	0.00112	0.00112	CcSEcCtD
Cefpodoxime—Diarrhoea—Methotrexate—ankylosing spondylitis	0.00108	0.00108	CcSEcCtD
Cefpodoxime—Dizziness—Methotrexate—ankylosing spondylitis	0.00104	0.00104	CcSEcCtD
Cefpodoxime—Vomiting—Methotrexate—ankylosing spondylitis	0.001	0.001	CcSEcCtD
Cefpodoxime—Rash—Methotrexate—ankylosing spondylitis	0.000996	0.000996	CcSEcCtD
Cefpodoxime—Dermatitis—Methotrexate—ankylosing spondylitis	0.000995	0.000995	CcSEcCtD
Cefpodoxime—Headache—Methotrexate—ankylosing spondylitis	0.00099	0.00099	CcSEcCtD
Cefpodoxime—Nausea—Methotrexate—ankylosing spondylitis	0.000939	0.000939	CcSEcCtD
